HLA class II associated risk and protection against multiple sclerosis-a Finnish family study (Q77451320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

HLA class II associated risk and protection against multiple sclerosis-a Finnish family study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

Mikko Laaksonen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Tomi Pastinen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Minna Sjöroos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Satu Kuokkanen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Juhani Ruutiainen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Marja Liisa Sumelahti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Helena Reijonen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Reijo Salonen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Juhani Wikström

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Martin Panelius

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Pentti J Tienari

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Jorma Ilonen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

140-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Analysis of HLA-class II DQA1, DQB1, DRB1 and DPB1 in Italian multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

HLA associations with multiple sclerosis in the Canary Islands.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

A full genome search in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

HLA-Dw1 and BfF as protective markers in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Geographical differences within Finland in the frequency of HLA-DQ genotypes associated with type 1 diabetes susceptibility. The Childhood Diabetes in Finland Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Dual origins of Finns revealed by Y chromosome haplotype variation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

The combination of HLA-DR1 and HLA-DR53 protects against MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 and *0302 alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

The Finnish population structure A genetic and genealogical study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

The epidemiology of multiple sclerosis: a general overview

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

HLA and prognosis in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

HLA-DR and -DQ associations with multiple sclerosis in Turkey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Susceptibility to type I diabetes: HLA-DQ and DR revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Unique HLA antigen frequencies in the Finnish population

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Reappraisal of HLA in multiple sclerosis: close linkage in multiplex families

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

The genetic structure of Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

Could HLA-DRB1 be the protective locus in rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900456-8

7 January 2021

10.1016/S0165-5728(01)00456-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777553%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference